Kevin Hsiao

Title: Kevin Hsiao: Innovator in ATP Detection Technology

Introduction

Kevin Hsiao is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the detection of adenosine triphosphate (ATP). His innovative work has implications for various applications, including cell viability assays and contamination detection.

Latest Patents

Kevin Hsiao holds a patent related to ATP detection. The patent focuses on devices, methods, and systems for detecting ATP in a sample. It also includes methods for removing ATP contamination from a sample and detecting intracellular ATP, which serves as a proxy for identifying live cells in the sample. This invention is crucial for researchers and industries that require accurate assessments of cell viability.

Career Highlights

Kevin Hsiao is currently employed at Promega Corporation, a leading company in the biotechnology sector. His role involves developing innovative solutions that enhance the capabilities of researchers in various fields. His expertise in ATP detection technology has positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Kevin has collaborated with Dongping Ma, a fellow researcher, to advance the understanding and application of ATP detection methods. Their combined efforts have contributed to the development of more effective tools for researchers in the life sciences.

Conclusion

Kevin Hsiao's work in ATP detection technology exemplifies the impact of innovation in biotechnology. His contributions not only enhance scientific research but also pave the way for future advancements in the field.